NCT01609270
Completed
Not Applicable
CardioRoot Post-Marketing Surveillance Registry
Maquet Cardiovascular6 sites in 3 countries52 target enrollmentNovember 2013
ConditionsCardiovascular Surgical Procedure
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiovascular Surgical Procedure
- Sponsor
- Maquet Cardiovascular
- Enrollment
- 52
- Locations
- 6
- Primary Endpoint
- Graft complications
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
Post-marketing surveillance registry of the CardioRoot graft.
Detailed Description
Study objective is to monitor the performance and safety of CardioRoot vascular grafts implanted in a thoracic position. Patient survival rates will be monitored as well as immediate and long-term complications.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients requiring a CardioRoot graft as per the CardioRoot Instructions for Use (IFU)
Exclusion Criteria
- •patients with contra-indications per CardioRoot IFU
- •patients requiring consecutive aortic surgery
- •patients with coronary artery disease
- •patients who require urgent or emergent surgery
Outcomes
Primary Outcomes
Graft complications
Time Frame: 1 year
Complications will be assessed out to one year post implantation.
Secondary Outcomes
- Subject mortality rate(30 days, 1 year)
Study Sites (6)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Medtronic Cardiac Surgery PMCF RegistryValve Disease, HeartNCT04073420Medtronic Cardiac Surgery2,700
Completed
Not Applicable
External Ventricular Drainage Post-Market Clinical Follow-up RegistryCerebrospinal; DisorderNCT05652296Integra LifeSciences Corporation120
Terminated
Not Applicable
Vascutek Anaconda™ Abdominal Aortic Aneurysm (AAA) Post-Market Surveillance RegistryAbdominal Aortic AneurysmNCT01744119Vascutek Ltd.318
Terminated
Not Applicable
An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG®Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALLNCT02455024Ariad Pharmaceuticals3
Completed
Not Applicable
Post-Market Registry of the ACIST CPM System and Navvus Catheter in Clinical PracticeCoronary Artery DiseaseNCT02060682Acist Medical Systems60